Georgia Andrew

491 total citations
5 papers, 42 citations indexed

About

Georgia Andrew is a scholar working on Hematology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Georgia Andrew has authored 5 papers receiving a total of 42 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Cancer Research and 1 paper in Public Health, Environmental and Occupational Health. Recurrent topics in Georgia Andrew's work include Acute Myeloid Leukemia Research (5 papers), Cancer Genomics and Diagnostics (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Georgia Andrew is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Cancer Genomics and Diagnostics (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Georgia Andrew collaborates with scholars based in United States, United Kingdom and Denmark. Georgia Andrew's co-authors include Charles Craddock, Sylvie Freeman, Naeem Khan, Shamyla Siddique, Rachel Protheroe, Andrew Peniket, Pramila Krishnamurthy, Gege Gui, Adriana Pleșa and Justin Loke and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

Georgia Andrew

5 papers receiving 41 citations

Peers

Georgia Andrew

HEMAT

MB

GENET

PHEOH

CR

Sophie Dimicoli‐Salazar France

I Hassan Pakistan

Gudrun Goehring Germany

Frédéric Millot France

Stephanie M. Kapsalis United States

Wenyan Cheng China

Kristi Romero United States

Lisa Gu United States

Émilie Lemasle France

Chloé Arfeuille France

Sophie Dimicoli‐Salazar France

Georgia Andrew

43 ×1.1

HEMAT

13 ×1.1

MB

19 ×2.1

GENET

7 ×0.8

PHEOH

4 ×0.7

CR

Citations per year, relative to Georgia Andrew Georgia Andrew (= 1×) peers Sophie Dimicoli‐Salazar

Countries citing papers authored by Georgia Andrew

Since Specialization

Citations

This map shows the geographic impact of Georgia Andrew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgia Andrew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgia Andrew more than expected).

Fields of papers citing papers by Georgia Andrew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgia Andrew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgia Andrew. The network helps show where Georgia Andrew may publish in the future.

Co-authorship network of co-authors of Georgia Andrew

This figure shows the co-authorship network connecting the top 25 collaborators of Georgia Andrew. A scholar is included among the top collaborators of Georgia Andrew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgia Andrew. Georgia Andrew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Gui, Gege, Christophe Roumier, Georgia Andrew, et al.. (2024). Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance. Leukemia. 38(8). 1667–1673. 9 indexed citations

2.

Andrew, Georgia, Gege Gui, Devdeep Mukherjee, et al.. (2023). Persistence of FLT3-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission. Blood. 142(Supplement 1). 2941–2941. 1 indexed citations

3.

Loke, Justin, Aimee Jackson, Shamyla Siddique, et al.. (2023). Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS. Blood Advances. 7(14). 3666–3676. 21 indexed citations

4.

Russell, Nigel H., Abin Thomas, Robert K. Hills, et al.. (2023). MRD Directed Treatment Intensification with Either FLAG-Ida or DA-Cladribine Improves Survival in Older AML Patients: Results from the NCRI AML18 Randomised Trial. Blood. 142(Supplement 1). 830–830. 4 indexed citations

5.

Dillon, Laura W., Gege Gui, Zoë C. Wong, et al.. (2022). Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.. Journal of Clinical Oncology. 40(16_suppl). 7006–7006. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact